SMTL ID : 3bzu.1

Crystal structure of human 11-beta-hydroxysteroid dehydrogenase(HSD1) in complex with NADP and thiazolone inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.25 Å

Oligo State

homo-tetramer

Ligands

4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 28 residues within 4Å: Chain A: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: A21.2 25 PLIP interactions: 25 interactions with chain A Hydrophobic interactions: A:L.209 Hydrogen bonds: A:G.35, A:S.37, A:S.37, A:K.38, A:I.40, A:R.60, A:S.61, A:T.86, A:M.87, A:N.113, A:I.115, A:Y.141, A:K.181, A:I.212, A:T.214, A:T.214, A:T.216 Water bridges: A:K.38, A:G.41, A:E.88, A:N.113, A:N.117, A:T.214 Salt bridges: A:R.60 NAP.3: 31 residues within 4Å: Chain B: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, N.117, V.136, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: A21.4 27 PLIP interactions: 27 interactions with chain B Hydrophobic interactions: B:L.209 Hydrogen bonds: B:G.35, B:S.37, B:S.37, B:K.38, B:I.40, B:R.60, B:S.61, B:T.86, B:T.86, B:M.87, B:N.113, B:I.115, B:Y.141, B:S.164, B:Y.177, B:K.181, B:I.212, B:I.212, B:T.214, B:T.214, B:T.216 Water bridges: B:G.41, B:T.116 Salt bridges: B:K.38, B:K.38, B:R.60 NAP.5: 30 residues within 4Å: Chain C: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: A21.6 22 PLIP interactions: 22 interactions with chain C Hydrophobic interactions: C:L.209 Hydrogen bonds: C:G.35, C:S.37, C:S.37, C:K.38, C:I.40, C:R.60, C:S.61, C:T.86, C:M.87, C:E.88, C:N.113, C:I.115, C:K.181, C:I.212, C:I.212, C:T.214, C:T.216 Water bridges: C:G.41, C:N.113 Salt bridges: C:K.38, C:R.60 NAP.7: 28 residues within 4Å: Chain D: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, G.85, T.86, M.87, N.113, H.114, I.115, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217 Ligands: A21.8 24 PLIP interactions: 24 interactions with chain D Hydrophobic interactions: D:L.209 Hydrogen bonds: D:G.35, D:S.37, D:S.37, D:K.38, D:I.40, D:R.60, D:T.86, D:T.86, D:M.87, D:N.113, D:I.115, D:S.164, D:Y.177, D:K.181, D:I.212, D:I.212, D:T.214, D:T.216 Water bridges: D:K.38, D:K.38, D:G.41 Salt bridges: D:K.38, D:R.60

4 x A21: (5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one(Non-covalent)

A21.2: 16 residues within 4Å: Chain A: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, V.174, Y.177, G.210, L.211, A.217, A.220, V.221, M.227 Ligands: NAP.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.115, A:T.118, A:L.120, A:Y.171, A:V.174, A:A.220 Hydrogen bonds: A:S.164, A:L.165, A:A.166, A:Y.177, A:Y.177 pi-Stacking: A:Y.177 A21.4: 16 residues within 4Å: Chain B: I.115, T.118, L.120, S.164, L.165, A.166, Y.171, V.174, Y.177, G.210, L.211, A.217, A.220, V.221, M.227 Ligands: NAP.3 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:I.115, B:T.118, B:L.120, B:Y.171, B:V.174, B:A.220 Hydrogen bonds: B:S.164, B:L.165, B:A.166, B:Y.177 pi-Stacking: B:Y.177 A21.6: 12 residues within 4Å: Chain C: I.115, S.164, L.165, A.166, Y.171, V.174, Y.177, G.210, L.211, A.217, A.220 Ligands: NAP.5 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:I.115, C:Y.171, C:V.174, C:A.220 Hydrogen bonds: C:S.164, C:L.165, C:A.166, C:Y.177, C:Y.177 pi-Stacking: C:Y.177 A21.8: 15 residues within 4Å: Chain D: T.118, L.120, S.164, L.165, A.166, Y.171, V.174, Y.177, G.210, L.211, A.217, A.220, V.221, M.227 Ligands: NAP.7 10 PLIP interactions: 10 interactions with chain D Hydrophobic interactions: D:T.118, D:L.120, D:Y.171, D:V.174, D:A.220 Hydrogen bonds: D:S.164, D:A.166, D:Y.177 pi-Stacking: D:Y.177 Halogen bonds: D:A.217

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hale, C. et al., Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor. Chem.Biol.Drug Des. (2008)

Release Date

2008-06-10

Peptides

Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Corticosteroid 11-beta-dehydrogenase isozyme 1

Related Entries With Identical Sequence